Clinical Trial of Chinese Medicine in the Treatment of Cough Variant Asthma

Clinical trial for Shufeng Wenfei Zhike granule in the Treatment of Cough Variant Asthma

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000002990

Enrollment

Unknown

Registered

2020-02-09

Start date

2020-02-29

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough variant asthma

Interventions

control group:placebo

experimental group:Shufeng Wenfei Zhike granule

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) The clinical diagnosis was CVA; (2) The syndrome differentiation of traditional Chinese medicine is cold fluid lurking in lung; (3) 18-65 years old; (4) Voluntary participation in the clinical trial, informed consent and signing of informed consent.

Exclusion criteria

Exclusion criteria: (1) Chronic cough caused by other causes (2) Alt, AST > upper limit of normal reference value 1.5 times or SCR > upper limit of normal reference value; (3) Have a long history of alcohol or drug abuse; (4) There are serious cardiovascular and cerebrovascular diseases; (5) Have mental or mental disorders; (6) Pregnant and lactating women; (7) Have a history of allergy to test drug ingredients; (8) The researchers think it is not suitable to participate in this clinical trial.

Design outcomes

Primary

Measure	Time frame
TCM symptom score;Cough symptom score;	—

Secondary

Measure	Time frame
Cough VAS score;Chinese LCQ score;	—

Countries

China

Contacts

Public ContactYang Kai

Oriental Hospital of Beijing University of Traditional Chinese Medicine

641179500@qq.com+86 15116992746

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026